BRIEF: Gavi seeks to claw back $224 million prepayment from Clover
Biotechnology firm Clover Biopharmaceuticals Ltd. (2197.HK) said on Monday that it received an arbitration claim on June 6 seeking return of a $224 million prepayment from global vaccine alliance Gavi.…
RELATED ARTICLES
- Dispute over Covid vaccines casts doubt on Clover Bio recovery
- Everest Medicines drives growth with AI-powered mRNA pipeline
- BRIEF: Jihong Group seeks up to $93 million in Hong Kong IPO
- Coconut water maker If seeks investor warmth in Hong Kong
- BRIEF: Synagistics to acquire Chinese AI firm for $30 million
Discover hidden China stock gems in our weekly newsletter